IL6 and COVID-19: Key findings of this investigation were as follows: Levels of LDL-C, HDL, TC, and TG all decreased significantly with increasing severity of COVID-19 while acute phase reactants like IL-6, Procalcitonin, CRP, and D-dimers were increased in this cohort.